Replies to post #171449 on Biotech Values

[oc631]

ENTA/ABBV are great LT HCV investments regardless of the knee-jerk reaction we may see today. Owning the stock today will put you in the LT cap gains category upon approval in 2015.

[DewDiligence]

I am hoping ENTA/ABBV will still be very competitive.

They still are. Please see the summary section of #msg-95103023.